Wainberg, Z., Enzinger, P., Qin, S., Yamaguchi, K., Wang, J., Zhou, X., . . . Kang, Y. Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer. Elsevier.
Chicago Style (17th ed.) CitationWainberg, Z.A, et al. Health-related Quality of Life with Bemarituzumab Plus MFOLFOX6 in Patients with FGFR2b-overexpressing, Advanced Gastric or Gastroesophageal Junction Cancer. Elsevier.
MLA (9th ed.) CitationWainberg, Z.A, et al. Health-related Quality of Life with Bemarituzumab Plus MFOLFOX6 in Patients with FGFR2b-overexpressing, Advanced Gastric or Gastroesophageal Junction Cancer. Elsevier.
Warning: These citations may not always be 100% accurate.